Azienda Ospedaliera San Camillo Forlanini /ID# 155644

Rome, Roma 00149

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease — Running, not enrolling